Emergent BioSolutions Inc (NYSE:EBS)

50.48
Delayed Data
As of May 22
 -1.12 / -2.17%
Today’s Change
29.15
Today|||52-Week Range
55.91
+8.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.5B

Company Description

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures that address public health and national security threats. It includes Chemical, Biological, Radiological, Nuclear and Explosive or CBRNE threats; as well as emerging infectious diseases. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Contact Information

Emergent BioSolutions, Inc.
400 Professional Drive
Gaithersburg Maryland 20879
P:(240) 631-3200
Investor Relations:
(301) 795-1877

Employees

Shareholders

Mutual fund holders45.80%
Other institutional39.43%
Individual stakeholders22.35%

Top Executives

Daniel J. Abdun-NabiChief Executive Officer & Director
Robert G. KramerPresident & Chief Operating Officer
Richard S. LindahlChief Financial Officer, Treasurer & Executive VP
W. James JacksonChief Scientific Officer & Senior Vice President
Sharon M. SolomonChief Information Officer & Senior Vice President